Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Lisboa, J. Dreyse, A. Morales, F. Saldías, O. Díaz (Santiago, Chile). Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD. Eur Respir J 2009; 34: Suppl. 53, 3263

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Effects of anti-inflammatory treatment on inflammatory infiltrate and ventilation parameters in patients with moderate COPD Source: Eur Respir J 2007; 30: Suppl. 51, 141s Year: 2007 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007 Effect of dupilumab on severe exacerbations and lung function in patients with baseline blood eosinophils =500 cells/µL Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004 Surrogate markers of airway inflammation are not increased in actively smoking mild to moderate asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 283s Year: 2001 Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013